Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
BRINTER logo — U.S 3D BioPrinted Tissue Platform company [TechStars‘24 Plug...

BRINTER

U.S 3D BioPrinted Tissue Platform company [TechStars‘24 Plug & Play '25] - Developing bioimplants for human Repairs.

Founded 2021 United States Santa Monica, United States 10 employees Seed Total: $1.95M

General Information

Company Name BRINTER
Founded Year 2021
Location United States Santa Monica, United States
Employees 10
Funding Stage Seed
Business Model B2B, D2C, Platform
Revenue Model Product Sales, Licensing, Service Fee
Social

BounceWatch is an independent company data service, not affiliated with BRINTER. To contact BRINTER, visit brinter.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does BRINTER compare?

A PDF of BRINTER and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting BRINTER soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About BRINTER

BRINTER, a startup founded in 2021 and headquartered in the United States, is pioneering the development of bio-synthetic implants for tissue repair, with an initial focus on tendon and ligament repairs. The company's mission is encapsulated in its slogan: U.S 3D BioPrinted Tissue Platform company [TechStars‘24 Plug & Play '25] - Developing bioimplants for human Repairs.

Having recently secured a $750.00K Seed investment as of 01 February 2023, BRINTER is positioned to capitalize on advancements in 3D bioprinting technology. This capital infusion is intended to propel the company forward in its research and commercialization efforts, offering a promising outlook for future growth in the burgeoning biotech sector.

The startup stands out in the medical tech industry by addressing an unmet need for bio-synthetic implants, making it an attractive consideration for investors seeking innovation in healthcare solutions. As a participant in programs like TechStars and Plug & Play, BRINTER benefits from a network of invaluable resources and mentorship.

Business keywords: 3D Bioprinting, Bioimplants, Tissue Engineering, Regenerative Medicine, Tendon Repair, Ligament Repair, Synthetic Implants, Human Tissue Repair, Healthcare Innovation, Medical Technology, Bioprinted Tissue Platforms

Services & Products

Development of 3D Bioprinted Implants
R&D in Regenerative Medicine
Manufacturing of BioPrinted Medical Devices
Tissue Engineering Innovation
Custom Implant Solutions

Target Customers

Orthopedic Surgeons Aesthetic Surgeons Regenerative Medicine Clinics Medical Device Manufacturers Healthcare Institutions

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Seed $750.00K -
01 Feb 2023
Seed €1.20M 1
Innovestor
Innovestor
01 Jun 2021

BRINTER Alternatives & Competitors

View All Alternatives
BRINTER vs
Cellbricks Therapeutics
Cellbricks Therapeutics Germany

Offering a scalable solution to restore lost tissue and organ function for millions of patients.

Venture round
31 employees
Biotechnology, Life Sciences
BRINTER vs
Anatomiz3D Medtech Private Limited
Anatomiz3D Medtech Private Limited India

Personalising Healthcare

15 employees
3D Printing
BRINTER vs
Linio Biotech
Linio Biotech Finland

Redefining skin regeneration

Seed
21 employees
Biotechnology, Life Sciences
View all alternatives

FAQ About BRINTER

U.S 3D BioPrinted Tissue Platform company [TechStars‘24 Plug & Play '25] - Developing bioimplants for human Repairs.
BRINTER was founded in 2021.
BRINTER is headquartered in Santa Monica, United States.
BRINTER has a B2B, D2C and Platform business model. Its revenue comes from Product Sales, Licensing and Service Fee.
BRINTER has approximately 10 employees.
BRINTER has completed 2 funding rounds, raising a total of $1.95M. The latest funding stage is Seed.
BRINTER offers: Development of 3D Bioprinted Implants, R&D in Regenerative Medicine, Manufacturing of BioPrinted Medical Devices, Tissue Engineering Innovation, Custom Implant Solutions.
Top alternatives and competitors to BRINTER include Cellbricks Therapeutics, Anatomiz3D Medtech Private Limited, Linio Biotech, China Regenerative Medicine International, CHIRON. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
BRINTER and Cellbricks Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for BRINTER, https://bouncewatch.com/company/brinter, updated 13 November 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout